- Published at
- by manilatimes.net
mixed
mixed
News for Cassava Sciences, Inc. (SAVA.MX)
- Published at
- by gurufocus.com
neutralneutralCassava Sciences (SAVA) Halts Simufilam Development for Alzheimer's
Summary: Cassava Sciences has halted its Alzheimer's drug development after failing Phase III trials. The company's stock has suffered a significant decl- Published at
- by gurufocus.com
neutralneutralCassava Sciences (SAVA) Faces Legal Challenge Over Alzheimer's Drug Simufilam
Cassava Sciences (SAVA) embroiled in legal battles and research controversy. Analysts project a 62.60% potential upside on SAVA's current stock price.- Published at
- by seekingalpha.com
neutralneutralCassava Sciences: Downside From Alzheimer's Results Possible Despite Developments (SAVA)
Cassava Sciences explores simufilam's potential for seizures in tuberous sclerosis. Results for Alzheimer's trials expected Q1/Q2 2025. Learn more on SAVA stock here.- Published at
- by benzinga.com
mixedmixedTesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday? - SPDR S&P 500 (ARCA:SPY)
Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%, down from 50.9% in January.- Published at
- by gurufocus.com
positivepositiveCassava Sciences Reports 2024 Financial Results and Provides Business Update
Top-line data for REFOCUS-ALZ, the second Phase 3 study of simufilam in Alzheimer's disease, expected late first-quarter/early second-quarter 2025License agreem- Published at
- by manilatimes.net
neutralneutral- Published at
- by manilatimes.net
neutralneutral- Published at
- by gurufocus.com
negativenegativeCassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA
PR NewswireNEW YORK, Feb. 10, 2025 NEW YORK, Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cassava Scienc- Published at
- by gurufocus.com
neutralneutralSAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Cassa- Published at
- by gurufocus.com
neutralneutralThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc. (SAVA) Shareholders
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cassava Sciences, Inc. ( SAVA). Shareholders wh- Published at
- by gurufocus.com
positivepositiveSAVA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action -- SAVA
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, In- Published at
- by gurufocus.com
positivepositiveCASSAVA SCIENCES, INC. (NASDAQ: SAVA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cassava Sciences, Inc. Investors of Upcoming Deadline
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Cassava Sciences, Inc. ( SAVA)? Did you purchase your- Published at
- by gurufocus.com
negativenegativeShareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA
PR NewswireNEW YORK, Feb. 3, 2025 NEW YORK, Feb. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cassava Sciences- Published at
- by gurufocus.com
positivepositiveSAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit
PR NewswireNEW YORK, Jan. 31, 2025 NEW YORK, Jan. 31, 2025 /PRNewswire/ --- Published at
- by gurufocus.com
positivepositiveROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action -- SAVA
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, In- Published at
- by gurufocus.com
positivepositiveCASSAVA SCIENCES, INC. (NASDAQ: SAVA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cassava Sciences, Inc. Investors of Upcoming Deadline
NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Cassava Sciences, Inc. ( SAVA)? Did you purchase your- Published at
- by gurufocus.com
neutralneutralClass Action Filed Against Cassava Sciences, Inc. (SAVA) - February 10, 2025 Deadline to Join - Contact The Gross Law Firm
PR NewswireNEW YORK, Jan. 27, 2025 NEW YORK, Jan. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cassava Scienc- Published at
- by investing.com
positivepositiveROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA- Published at
- by investing.com
negativenegativeSAVA Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc. (SAVA) By Investing.com
SAVA Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc. (SAVA)